When combined with GLP-1 therapy, berberine may provide additive benefits for blood sugar control
It is not a drug and is not intended for human or veterinary use
Compounded versions have not been evaluated by the FDA and may pose safety risks
Symptoms of real deficiency include fatigue, tingling or numbness in hands and feet, memory and concentration issues, mouth ulcers and pale skin, and a GP blood test is the only reliable way to confirm it
BPC-157 promotes angiogenesis, which is beneficial for tissue repair but contraindicated in certain clinical contexts
The new 7.2mg dose produces approximately 20.7% weight loss, essentially matching Mounjaro 15mg, compared to 14.9% at the standard 2.4mg dose.